Citadel Receives Insider Trading Subpoena
Tweet
Share
E-mail
According to Fox Business Network's Charlie Gasparino, Ken Griffin's Citadel hedge fund received a "wide ranging subpoena" from federal investigators related to the vast insider trading probe.
"They got a subpoena. It's the same subpoena that sources tell FOX Business Network that Steve Cohen over at SAC Capital got. It's a wide ranging subpoena and it dates back to 2008 asking for information on certain stocks. From what I understand, it's not just healthcare stocks, which has been a primary focus," Gasparino stated.
Two other hedge funds have have received subpoenas, Gasparino also reported. "We have put calls into Millennium Capital Management and Maverick Capital Management and we are waiting to hear back to them."
UPDATE: Maverick Capital has contacted us and said they have not received a subpoena in connection with the recent insider trading probe.
"They got a subpoena. It's the same subpoena that sources tell FOX Business Network that Steve Cohen over at SAC Capital got. It's a wide ranging subpoena and it dates back to 2008 asking for information on certain stocks. From what I understand, it's not just healthcare stocks, which has been a primary focus," Gasparino stated.
Two other hedge funds have have received subpoenas, Gasparino also reported. "We have put calls into Millennium Capital Management and Maverick Capital Management and we are waiting to hear back to them."
UPDATE: Maverick Capital has contacted us and said they have not received a subpoena in connection with the recent insider trading probe.
Serious News for Serious Traders! Try StreetInsider.com Premium Free!
You May Also Be Interested In
- Ryan Cohen isn't done chasing eBay (EBAY) - Barron's
- Interactive Brokers offers UK clients access to SpaceX IPO
Create E-mail Alert Related Categories
Insiders' Blog, Rumors, Trader TalkRelated Entities
SAC Capital, Citadel, Ken Griffin, Charles Gasparino, Steven A. Cohen, Maverick Capital, Hedge FundsSign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!
